ORTO BIO LIMITED
Significant control: Prof. Sunetra Gupta (25–50%), Alexander Orlando Harold Caccia (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Orto Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Orto Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ORTO BIO LIMITED is an active private limited company (company number 15577521) incorporated on 19 March 2024, registered in Kingston Upon Thames. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £90k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the top quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
Ownership and control
- Prof. Sunetra Gupta
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr. Alexander Orlando Harold Caccia
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 19 March 20242 yrs ago
- Next accounts due
- 31 December 2026in 63 days
- Confirmation statement due
- 2 April 2027in 155 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £90k | — | — | £4,596 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £90,146 at 31 March 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 20.61
- Incorporated two to five years agoIncorporated 19 March 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 155 days
- Next accounts duein 63 days
- Accounts period endNet assets £90k · micro accounts
- Incorporated
Similar companies in Greater London
- EBIXIGEN LIMITEDRuislip, · inc. Mar 2024
- RESIGENIX LTDFeltham · inc. Mar 2024
- SWIFT NEURO CONSULTING LTDPotters Bar · inc. May 2024
- BIOSYSION LTDWoodford Green · inc. Jan 2024
- TAIRON LIMITEDBromley · inc. Jan 2024
- LYKKE RESEARCH LTDEast Molesey · inc. May 2024
All companies incorporated on 19 March 2024 · in Mar 2024.
Reminders for ORTO BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.